Top Benign Prostatic Hyperplasia Companies, Leaders & Major Players

This list of the top companies of Benign Prostatic Hyperplasia is drawn from assessments by Mordor Intelligence analysts and expert advisors via their extensive research to identify the brands, leaders and major players active in Benign Prostatic Hyperplasia sector.

Top Benign Prostatic Hyperplasia Companies

  1. Abbvie

  2. Eli Lilly and Company

  3. Merck

  4. Boehringer Ingelheim

  5. Astellas Pharma

*Disclaimer: Top companies sorted in no particular order

Benign Prostatic Hyperplasia Market Major Players

Benign Prostatic Hyperplasia - Competitive Concentration

Benign Prostatic Hyperplasia Market Concentration

List of Benign Prostatic Hyperplasia Companies

  • Abbvie

  • Astellas Pharma

  • GlaxoSmithKline

  • Pfizer

  • Eli Lilly and Company

  • Viatris

  • Merck

  • Teva Pharmaceutical Industries

  • Sun Pharmaceuticals Industries

  • Dr. Reddy’s Laboratories Ltd.

  • Lupin

  • Cipla

  • Torrent Pharmaceuticals

  • Recordati S.p.A.

  • Eisai

  • Ferring Pharmaceuticals

  • Sandoz (Novartis Division)

  • Sanofi

  • Alkem Laboratories Ltd.

  • Zydus Lifesciences Ltd.

Get more insights on Benign Prostatic Hyperplasia industry from our comprehensive report

Complete your form and get your market insights delivered to your inbox

Takes less than 10 seconds